Worldwide’s Commitment to Advancing CNS Disorder Research

Worldwide Clinical Trials has been at the forefront of research on central nervous system disorders for 30+ years, participating in early studies of dementia-related illnesses. Since the time when many of our commonly known neurologic conditions were still mysteries, Worldwide has been exploring symptoms and, more recently, biomarkers, to advance knowledge and facilitate the development, approval, and release to market of important treatment therapies.

Today, with many central nervous system disorders becoming more commonly understood from a clinical and scientific perspective, Worldwide continues to apply its uncommon tenacity to research in lesser-known indications. Our experience in rare diseases, combined with our broad global reach, gives us the expertise and resources to explore more central nervous system disorders.